Allogeneic stem cell therapy (Staburo/Gemeinsamer Bundesausschuss)

N/A

Report date: 2025/04/23 20:01:04

Base Information

Drug NameAllogeneic stem cell therapy (Staburo/Gemeinsamer Bundesausschuss)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGemeinsamer Bundesausschuss (Gba)Staburo Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGemeinsamer Bundesausschuss (Gba)Staburo Gmbh
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A